Gelnova Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.30 Cr
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.66 Cr
- Satisfied Charges ₹ 101.69 Cr
- Revenue Growth -0.52%
- Profit Growth -49.11%
- Ebitda 16.43%
- Net Worth -3.50%
- Total Assets 10.47%
About Gelnova Laboratories (India)
Gelnova Laboratories (India) Private Limited (GLIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 January 1997 and has a history of 28 years and one month. Its registered office is in Navi Mumbai, Maharashtra, India.
The Corporate was formerly known as Franco Fabrics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹18.66 Cr. The company has closed loans amounting to ₹101.69 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bharati Thakkar, Jatin Thakkar, and Dhananjay Desai serve as directors at the Company.
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U17000MH1997PTC105076
- Company No.
105076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Gelnova Laboratories (India) Private Limited offer?
Gelnova Laboratories (India) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Mineral Supplement, Cough Syrup, Cough Medicine, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Fitness Supplements.
Who are the key members and board of directors at Gelnova Laboratories (India)?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jatin Thakkar ![]() | Managing Director | 18-Aug-2000 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharati Thakkar ![]() | Director | 18-Aug-2000 | Current |
Dhananjay Desai ![]() | Director | 15-Oct-2009 | Current |
Financial Performance of Gelnova Laboratories (India).
Gelnova Laboratories (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.52% decrease. The company also saw a substantial fall in profitability, with a 49.11% decrease in profit. The company's net worth dipped by a decrease of 3.5%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gelnova Laboratories (India)?
In 2023, Gelnova Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹18.66 Cr
₹101.69 Cr
Charges Breakdown by Lending Institutions
- Others : 18.00 Cr
- Axis Bank Limited : 0.66 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
12 Oct 2023 | Others | ₹18.00 Cr | Open |
19 May 2023 | Axis Bank Limited | ₹6.60 M | Open |
09 Mar 2021 | Others | ₹3.01 Cr | Satisfied |
29 Jun 2020 | Others | ₹19.00 Cr | Satisfied |
31 Jan 2018 | Others | ₹17.00 Cr | Satisfied |
How Many Employees Work at Gelnova Laboratories (India)?
Gelnova Laboratories (India) has a workforce of 82 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gelnova Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gelnova Laboratories (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.